SEOMGECOD clinical guideline for unknown primary cancer (2021)
Clin. transl. oncol. (Print)
; 24(4): 681-692, abril 2022. tab
Article
in English
| IBECS
| ID: ibc-203772
Responsible library:
ES1.1
Localization: ES15.1 - BNCS
ABSTRACT
Cancer of unknown primary site (CUP) is defined as a heterogeneous group of tumors that appear as metastases, and of which standard diagnostic work-up fails to identify the origin. It is considered a separate entity with a specific biology, and nowadays molecular characteristics and the determination of actionable mutations may be important in a significant group of patients. In this guide, we summarize the diagnostic, therapeutic, and possible new developments in molecular medicine that may help us in the management of this unique disease entity.
Full text:
Available
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Neoplasms, Unknown Primary
Limits:
Humans
Language:
English
Journal:
Clin. transl. oncol. (Print)
Year:
2022
Document type:
Article
Institution/Affiliation country:
Hospital Durán i Reynals-ICO Hospitalet/Spain
/
Hospital Germans Trias I Pujol -ICO Badalona/Spain
/
Hospital Lluís Alcanys de Xàtiva/Spain
/
Hospital Miguel Servet/Spain
/
Hospital Universitario 12 de Octubre/Spain
/
Hospital Universitario Puerta de Hierro Majadahonda/Spain
/
Hospital Universitario Ramón y Cajal/Spain
/
Hospital Universitario Virgen Macarena/Spain
/
Hospital de Sant Joan Despí Moisés Broggi-ICO Hospitalet/Spain
/
Hospital Álvaro Cunqueiro-IIGS/Spain